Loading clinical trials...
Loading clinical trials...
Rabbit Anti-thymocyte Globulin Versus IL2 Receptor Antagonists in Combination With Tacrolimus, Corticosteroids and Mycophenolate Mofetil in a Predominantly High Risk Kidney Transplant Population.
Conditions
Interventions
Rabbit Antithymocyte globulin
Daclizumab
Locations
1
United States
Medical University of South Carolina
Charleston, South Carolina, United States
Start Date
March 1, 2009
Primary Completion Date
July 1, 2012
Completion Date
July 1, 2014
Last Updated
April 26, 2016
NCT07146854
NCT04163614
NCT04580420
NCT06190717
NCT05654103
NCT03994471
Lead Sponsor
Medical University of South Carolina
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions